4521KAKEN PHARMACEUTICAL CO.,LTD.¥ --

KAKEN PHARMACEUTICAL CO.,LTD.

4521

TSE PrimePharmaceuticals

¥ -

View detailed cash flow statement data.

paymentsCash Flow (CF) Summary

Updated: 2026/03/31FY2026

Operating CF

-110.8B JPY

YoY -137.2%

Investing CF

3.1B JPY

YoY +101.6%

Financing CF

-88.4B JPY

YoY -64.7%

Free CF

-107.6B JPY

YoY -206.3%

Cash Flow Trend (5 Years)

Investing CF

Operating CF

Financing CF

297.8億0

-196.5億

0000

133.4億

-78.9億

-81.3億

2022

92.5億

-26.3億

-69.9億

2023

25.8億

-58.5億

-56.6億

2024

297.8億

-196.5億

-53.7億

2025

3.1億

-110.8億

-88.4億

2026

analyticsInvestment Efficiency Analysis

Operating CF vs Investing CF

Operating CF

Investing CF

342.5億171.2億0-171.2億-342.5億

20222023202420252026

waterfall_chartCash Flow Bridge (FY2026 Annual)

Beginning / Ending

Increase

Decrease

800億700億600億500億400億

703.1億

Opening Cash

-110.8億

Operating CF

3.1億

Investing CF

-88.4億

Financing CF

Other

507.1億

Closing Cash

Cash Flow Statement

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan